Results 71 to 80 of about 11,081 (214)
Weight management and current options in pharmacotherapy: Orlistat and Sibutramine
BACKGROUND: Chronic obesity is associated with various cardiovascular disorders, including diabetes, dyslipidemia, and hypertension. Pharmacotherapy with antiobesity agents is an important management strategy in conjunction with lifestyle interventions ...
Thomas, Graham; id_orcid +3 more
core +1 more source
ABSTRACT Background As poor sleep negatively impacts on adiposity, there is interest in examining whether improving sleep can improve adiposity markers. We reviewed studies aimed at improving sleep using (1) cognitive behavioral therapy for insomnia (CBT‐I) and/or sleep hygiene and (2) sleep extension on adiposity markers, dietary intake, and physical ...
Samiul A. Mostafa +7 more
wiley +1 more source
Does orlistat cause acute kidney injury?
Orlistat is an inhibitor of gastric and pancreatic lipase with proven efficacy in the augmentation and maintenance of weight loss. Although its use has been limited by troublesome but benign gastrointestinal side effects, it has more recently been ...
Amit X. Garg +2 more
core +1 more source
Impact of Dietary Lipids on Colonic Function and Microbiota: An Experimental Approach Involving Orlistat-Induced Fat Malabsorption in Human Volunteers [PDF]
OBJECTIVES: High-fat diets alter gut microbiota and barrier function, inducing metabolic endotoxemia and low-grade inflammation. Whether these effects are due to the high dietary lipid content or to the concomitant decrease of carbohydrate intake is ...
Carrasco-Pozo, Catalina +18 more
core +1 more source
ABSTRACT Obesity is a leading risk factor for premature morbidity and mortality, and an increasing public health challenge. This review aimed to systematically identify and appraise national and international clinical guidelines for the management of obesity in adults.
Paul Doody +7 more
wiley +1 more source
Background: Orlistat, a weight loss medication, is often less effective due to poor adherence to the dietary and exercise recommendations. However, its effectiveness is often compromised by poor adherence to recommended lifestyle changes and side effects
Khin Maung Win +5 more
doaj +1 more source
Orlistat in the prevention of diabetes in the obese patient
Marcio C Mancini, Alfredo HalpernObesity and Metabolic Syndrome Group, Endocrinology and Metabolism Department, Faculty of Medicine, University of São Paulo, São Paulo, SP, BrazilAbstract: There has been an increase in the concern about ...
Marcio C Mancini, Alfredo Halpern
core
The essential oils of three Origanum species were chemically characterized and evaluated for their antioxidant and enzyme inhibitory activities. The different compositions confer selective bioactivities: O. vulgare exhibits good antioxidant and α‐glucosidase inhibitory activity, O. majorana shows promising tyrosinase inhibition, and O.
Giuseppe Amato +6 more
wiley +1 more source
ORLISTAT : Kan orlistat ha andra hälsoeffekter i kroppen förutom viktminskningseffekten?
Bakgrund: I dagens samhälle med en kombination av allt mer stillasittande livsstil och tillgång till ett brett utbud av kaloririka livsmedel har det lett till en global epidemi av övervikt och fetma som är en riskfaktor för många sjukdomar.
Mohammadshahi, Faisal
core +1 more source
Oral aphthous ulcers associated with orlistat
Orlistat, a reversible inhibitor of gastrointestinal lipase, is indicated for obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet.
Sheikh-Taha, Marwan
core +1 more source

